View of Inflammatory and Metabolic Biomarker Alterations Associated with Long-Term Metformin and Glibenclamide Therapy in Type 2 Diabetes

Return to Article Details Inflammatory and Metabolic Biomarker Alterations Associated with Long-Term Metformin and Glibenclamide Therapy in Type 2 Diabetes Download Download PDF